Product Information
OXYBUTYNIN CL ER 15 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1253 per EA under NDC 68382025701. Its NADAC has been published 433 times since May 9, 2018.
FDA first approved this application on Jun 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382025701
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202332FDA Approved
6/26/2017
TE Code
AB
On Market Since
8/10/2017
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 15 MG TABLET has been published 433 times since May 9, 2018, and over the history we have for it it has declined 74.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1253 per EA |
|---|---|
| All-time high | $0.5636 (Aug 15, 2018) |
| All-time low | $0.0936 (Apr 17, 2024) |
| 52-week high | $0.1336 |
| 52-week low | $0.1161 |
| Median price | $0.1907 |
| Average price | $0.2268 |
| Largest weekly change | +38.9% (May 22, 2024) |
| Weeks tracked | 433 |
| Tracking since | May 9, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the oxybutynin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 15 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1253 per EA (NDC 68382025701), effective Aug 19, 2026.
How has the price of OXYBUTYNIN CL ER 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has declined 74.5%. It has been tracked across 433 weekly CMS publications since May 9, 2018.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 15 MG TABLET?
Since May 9, 2018, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has ranged from a low of $0.0936 (Apr 17, 2024) to a high of $0.5636 (Aug 15, 2018), with a median of $0.1907 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 15 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of OXYBUTYNIN CL ER 15 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OXYBUTYNIN CL ER 15 MG TABLET?
OXYBUTYNIN CL ER 15 MG TABLET (NDC 68382025701) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.